Literature DB >> 12605547

Candidate gene case-control studies.

Ann K Daly1.   

Abstract

Two main approaches to the identification of genes are involved in polygenic diseases. Use of family studies has generally been the preferred approach up until recently, but this is only feasible if the genetic component of the disease is relatively strong and DNA samples are available from other family members. Population case-control studies are useful both as an alternative and an adjunct to family studies. These can involve either whole genome scanning or candidate gene approaches. While whole genome scanning is likely to be widely used in the future once more information on genome-wide single nucleotide polymorphism distributions is available, at present, candidate gene studies are more feasible. When performing candidate gene case-control studies factors such as study design, methods for recruitment of case and controls, selection of candidate genes, functional significance of polymorphisms chosen for study and statistical analysis require close attention to ensure that only genuine associations are detected. Some examples of the successful use of candidate gene case-control studies are discussed and, to illustrate some potential problems in the design and interpretation of association studies, some specific examples of association studies on cancer are considered.

Entities:  

Mesh:

Year:  2003        PMID: 12605547     DOI: 10.1517/phgs.4.2.127.22629

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  6 in total

Review 1.  Human pharmacogenomic variations and their implications for antifungal efficacy.

Authors:  Joseph Meletiadis; Stephen Chanock; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Multi-institutional Study of Outcomes After Pediatric Heart Transplantation: Candidate Gene Polymorphism Analysis of ABCC2.

Authors:  Gilbert J Burckart; William D Figg; Maria M Brooks; Dionna J Green; Sarah M Troutman; Robert Ferrell; Richard Chinnock; Charles Canter; Linda Addonizio; Daniel Bernstein; James K Kirklin; David Naftel; Douglas K Price; Tristan M Sissung; Diana M Girnita; Adriana Zeevi; Steven A Webber
Journal:  J Pediatr Pharmacol Ther       Date:  2014-01

3.  Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.

Authors:  Vibeke Andersen; Jane Christensen; Anja Ernst; Bent A Jacobsen; Anne Tjønneland; Henrik B Krarup; Ulla Vogel
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

Review 4.  Genetic polymorphisms associated with acute lung injury.

Authors:  Anita J Reddy; Steven R Kleeberger
Journal:  Pharmacogenomics       Date:  2009-09       Impact factor: 2.533

5.  Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.

Authors:  Li Liu; Alexander Pertsemlidis; Liang-Hao Ding; Michael D Story; Martin H Steinberg; Paola Sebastiani; Carolyn Hoppe; Samir K Ballas; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

6.  Allelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study.

Authors:  Jose Perez de los Cobos; Montserrat Baiget; Joan Trujols; Nuria Sinol; Victor Volpini; Enrique Banuls; Francesc Calafell; Elena Luquero; Elisabeth del Rio; Enric Alvarez
Journal:  Behav Brain Funct       Date:  2007-06-01       Impact factor: 3.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.